Drugs / Phenserine
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06774261 Comparator | Feb → Dec 2025 | Alzheimer disease, cognitive impairment with or without cerebellar ataxia | Helse Stavanger HF | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Phenserine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06774261 ↗ |
| Action | Inhibit | “Phenserine is a next generation AChE inhibitor” NCT06774261 ↗ |
| Route | Oral | “oral phenserine” NCT06774261 ↗ |